TREATMENT OF COMPLICATED FORMS OF CHRONIC VENOUS INSUFFICIENCY

In Moscow alone, according to the Russian Association of Phlebologists, CVI affects 67% of the active working-age population. Among the factors leading to the development of venous leg ulcers, the most common is chronic venous insufficiency accounting for more than 50%. Trophic lesions against a bac...

Full description

Bibliographic Details
Main Authors: I. G. Uchkin, I. T. Khadzhishvili, A. A. Akulova
Format: Article
Language:Russian
Published: Remedium Group LTD 2017-06-01
Series:Амбулаторная хирургия
Subjects:
Online Access:https://www.a-surgeon.ru/jour/article/view/71
id doaj-8a8c3db8210a40deba9b82f65975f472
record_format Article
spelling doaj-8a8c3db8210a40deba9b82f65975f4722021-08-18T08:53:00ZrusRemedium Group LTDАмбулаторная хирургия2712-87412782-25912017-06-0101-2404371TREATMENT OF COMPLICATED FORMS OF CHRONIC VENOUS INSUFFICIENCYI. G. Uchkin0I. T. Khadzhishvili1A. A. Akulova2People's Friendship UniversityPeople's Friendship UniversityPeople's Friendship UniversityIn Moscow alone, according to the Russian Association of Phlebologists, CVI affects 67% of the active working-age population. Among the factors leading to the development of venous leg ulcers, the most common is chronic venous insufficiency accounting for more than 50%. Trophic lesions against a background of CVI cause long-term disability and invalidity in people in their most able-bodied and active ages, lead to considerable limitations in the basic spheres of life, from the ability to work to capacity for independent movement and self-care, thus reducing the quality of life. The total number of patients with a history of or currently suffering from venous trophic disorders of the lower limbs is 6% of the population. The incidence is increased in patients in older age groups, and complete elimination of the disease can only be achieved in every tenth patient. Even in cases of closure of trophic defects, the risk of recurrence is high. The article tells about the use of Actovegin®, its mechanism of action at different levels, as well as the etiology of CVI and its complicated forms, the appropriateness and adequacy of medical treatment with Actovegin®.https://www.a-surgeon.ru/jour/article/view/71актовегин®хвнварикозная болезньтрофические расстройстваклинические исследованияконсервативное лечение
collection DOAJ
language Russian
format Article
sources DOAJ
author I. G. Uchkin
I. T. Khadzhishvili
A. A. Akulova
spellingShingle I. G. Uchkin
I. T. Khadzhishvili
A. A. Akulova
TREATMENT OF COMPLICATED FORMS OF CHRONIC VENOUS INSUFFICIENCY
Амбулаторная хирургия
актовегин®
хвн
варикозная болезнь
трофические расстройства
клинические исследования
консервативное лечение
author_facet I. G. Uchkin
I. T. Khadzhishvili
A. A. Akulova
author_sort I. G. Uchkin
title TREATMENT OF COMPLICATED FORMS OF CHRONIC VENOUS INSUFFICIENCY
title_short TREATMENT OF COMPLICATED FORMS OF CHRONIC VENOUS INSUFFICIENCY
title_full TREATMENT OF COMPLICATED FORMS OF CHRONIC VENOUS INSUFFICIENCY
title_fullStr TREATMENT OF COMPLICATED FORMS OF CHRONIC VENOUS INSUFFICIENCY
title_full_unstemmed TREATMENT OF COMPLICATED FORMS OF CHRONIC VENOUS INSUFFICIENCY
title_sort treatment of complicated forms of chronic venous insufficiency
publisher Remedium Group LTD
series Амбулаторная хирургия
issn 2712-8741
2782-2591
publishDate 2017-06-01
description In Moscow alone, according to the Russian Association of Phlebologists, CVI affects 67% of the active working-age population. Among the factors leading to the development of venous leg ulcers, the most common is chronic venous insufficiency accounting for more than 50%. Trophic lesions against a background of CVI cause long-term disability and invalidity in people in their most able-bodied and active ages, lead to considerable limitations in the basic spheres of life, from the ability to work to capacity for independent movement and self-care, thus reducing the quality of life. The total number of patients with a history of or currently suffering from venous trophic disorders of the lower limbs is 6% of the population. The incidence is increased in patients in older age groups, and complete elimination of the disease can only be achieved in every tenth patient. Even in cases of closure of trophic defects, the risk of recurrence is high. The article tells about the use of Actovegin®, its mechanism of action at different levels, as well as the etiology of CVI and its complicated forms, the appropriateness and adequacy of medical treatment with Actovegin®.
topic актовегин®
хвн
варикозная болезнь
трофические расстройства
клинические исследования
консервативное лечение
url https://www.a-surgeon.ru/jour/article/view/71
work_keys_str_mv AT iguchkin treatmentofcomplicatedformsofchronicvenousinsufficiency
AT itkhadzhishvili treatmentofcomplicatedformsofchronicvenousinsufficiency
AT aaakulova treatmentofcomplicatedformsofchronicvenousinsufficiency
_version_ 1721203448794316800